GIARDINA, Annarita
 Distribuzione geografica
Continente #
NA - Nord America 3.557
EU - Europa 1.607
AS - Asia 1.527
SA - Sud America 168
AF - Africa 41
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.907
Nazione #
US - Stati Uniti d'America 3.507
SG - Singapore 619
CN - Cina 411
RU - Federazione Russa 384
FI - Finlandia 327
IT - Italia 265
DE - Germania 137
BR - Brasile 135
HK - Hong Kong 131
UA - Ucraina 106
VN - Vietnam 104
PL - Polonia 79
IE - Irlanda 75
GB - Regno Unito 73
FR - Francia 64
JP - Giappone 59
KR - Corea 40
SE - Svezia 38
IN - India 32
BD - Bangladesh 28
TR - Turchia 24
CA - Canada 23
MX - Messico 16
BE - Belgio 12
IQ - Iraq 11
NL - Olanda 11
AR - Argentina 9
ES - Italia 8
ID - Indonesia 8
VE - Venezuela 8
EC - Ecuador 7
SA - Arabia Saudita 7
CR - Costa Rica 6
JO - Giordania 6
KE - Kenya 6
MA - Marocco 6
ZA - Sudafrica 6
CI - Costa d'Avorio 5
GE - Georgia 5
LT - Lituania 5
PK - Pakistan 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
EG - Egitto 4
GR - Grecia 4
IR - Iran 4
RO - Romania 4
AT - Austria 3
AU - Australia 3
CL - Cile 3
EU - Europa 3
KG - Kirghizistan 3
LB - Libano 3
PY - Paraguay 3
SN - Senegal 3
TW - Taiwan 3
CH - Svizzera 2
CO - Colombia 2
CZ - Repubblica Ceca 2
KZ - Kazakistan 2
MY - Malesia 2
PH - Filippine 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GM - Gambi 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 6.907
Città #
Singapore 480
Ashburn 407
Fairfield 372
Woodbridge 216
Chandler 199
Seattle 159
San Jose 153
Houston 151
Wilmington 146
Cambridge 143
Hong Kong 127
Ann Arbor 116
Council Bluffs 98
Chicago 92
Moscow 84
Los Angeles 82
Beijing 79
Dublin 75
Helsinki 71
Santa Clara 69
Zgierz 69
Palermo 64
Jacksonville 62
Tokyo 56
Dallas 53
Medford 51
Frankfurt am Main 47
New York 46
The Dalles 45
Altamura 44
Nanjing 42
Princeton 33
Lauterbourg 31
Des Moines 30
Ho Chi Minh City 30
Lawrence 27
Hefei 26
Boardman 25
San Diego 23
Shenyang 22
Jinan 21
Salt Lake City 20
Dearborn 17
Hanoi 17
Nanchang 16
Phoenix 15
São Paulo 15
Changsha 14
Tulsa 14
Tianjin 12
Brussels 11
Buffalo 11
Guangzhou 11
London 10
Milan 10
Zhengzhou 10
Boston 9
Da Nang 9
Hebei 9
Jiaxing 9
Seoul 9
Sterling 9
Tampa 9
Warsaw 9
Denver 8
Ningbo 8
Stockholm 8
Venice 8
Amsterdam 7
Dulles 7
Düsseldorf 7
Kumar 7
Ludwigshafen am Rhein 7
Poplar 7
San Mateo 7
Seongnam 7
Verona 7
Amman 6
Chennai 6
City of London 6
Elk Grove Village 6
Istanbul 6
Izmir 6
Montreal 6
Orem 6
Ottawa 6
Rio de Janeiro 6
San Francisco 6
Abidjan 5
Brooklyn 5
Caracas 5
Cardiff 5
Genova 5
Haiphong 5
Hải Dương 5
Johannesburg 5
Manchester 5
Piscataway 5
San José 5
Shanghai 5
Totale 4.662
Nome #
Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience 309
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 290
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs 285
Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response 284
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis 282
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 280
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. 278
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity. 276
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis 254
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. 238
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes 238
Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. 233
Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome 228
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 227
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 224
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis 220
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients 213
Physical capacity in performing daily activities is reduced in scleroderma patients with early lung involvement 211
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. 191
AUTOPHAGY, BUT NOT THE UNFOLDED PROTEIN RESPONSE, REGULATES THE EXPRESSION OF IL-23 IN THEGUT OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND SUBCLINICAL GUT INFLAMMATION 185
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 174
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. 170
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. 162
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 161
Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation. 160
Reduced exercise capacity and impaired pulmonary function in patients with scleroderma 155
Nutritional evaluation and physical activity in scleroderma patients 154
Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion 147
Cell Immunity in Inflammatory Vasculitis 147
Successful intravenous immunoglobulin treatment for steroid-resistant eosinophilic enteritis in a patient with systemic lupus erythematosus. 137
Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity. 124
NKP44+NK cells are expanded and produce high amounts of IL-22 in the salivary glands of Sjrogen syndrome patients 123
Pulmonary functional and radiological correlations of nutritional status and physical activity in systemic sclerosis 105
Critical importance of patient-reported outcomes for a comprehensive assessment of psoriatic arthritis patients 104
No detection of hidden HBV-DNA in patients with various rheumatic diseases treated anti-TNF agents. A two-year prospective study. 98
VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies 10
Totale 7.077
Categoria #
all - tutte 22.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 0 0 0 0 28 44
2021/2022418 14 113 15 5 11 14 24 21 38 56 42 65
2022/2023505 43 119 11 54 69 75 23 33 50 6 17 5
2023/2024225 10 37 9 15 19 53 14 14 2 10 11 31
2024/2025828 6 44 50 55 32 18 29 45 26 81 239 203
2025/20262.600 186 47 137 163 227 398 455 234 187 471 95 0
Totale 7.077